vs
Spero Therapeutics, Inc.（SPRO）与TRANSACT TECHNOLOGIES INC（TACT）财务数据对比。点击上方公司名可切换其他公司
Spero Therapeutics, Inc.的季度营收约是TRANSACT TECHNOLOGIES INC的1.1倍（$12.6M vs $11.5M），Spero Therapeutics, Inc.同比增速更快（24080.8% vs 11.9%），过去两年Spero Therapeutics, Inc.的营收复合增速更高（847.7% vs 3.5%）
该公司相关归属主体罗珀技术公司是一家控股集团，主要投资控股科技领域的各类企业，业务覆盖多个科技细分赛道，依托旗下子公司开展多元化科技业务布局。
SPRO vs TACT — 直观对比
营收规模更大
SPRO
是对方的1.1倍
$11.5M
营收增速更快
SPRO
高出24068.8%
11.9%
两年增速更快
SPRO
近两年复合增速
3.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $12.6M | $11.5M |
| 净利润 | $31.5M | — |
| 毛利率 | — | 47.6% |
| 营业利润率 | — | -10.1% |
| 净利率 | 250.7% | — |
| 营收同比 | 24080.8% | 11.9% |
| 净利润同比 | 250.9% | — |
| 每股收益（稀释后） | $0.56 | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收SPROTACT
| Q4 25 | $12.6M | $11.5M | ||
| Q3 25 | $0 | $13.2M | ||
| Q2 25 | $0 | $13.8M | ||
| Q1 25 | $12.0K | $13.1M | ||
| Q4 24 | $52.0K | $10.2M | ||
| Q3 24 | $65.0K | $10.9M | ||
| Q2 24 | $114.0K | $11.6M | ||
| Q1 24 | $140.0K | $10.7M |
净利润SPROTACT
| Q4 25 | $31.5M | — | ||
| Q3 25 | $-7.4M | $15.0K | ||
| Q2 25 | $-1.7M | $-143.0K | ||
| Q1 25 | $-13.9M | $19.0K | ||
| Q4 24 | — | — | ||
| Q3 24 | $-17.1M | $-551.0K | ||
| Q2 24 | $-17.9M | $-319.0K | ||
| Q1 24 | $-12.7M | $-1.0M |
毛利率SPROTACT
| Q4 25 | — | 47.6% | ||
| Q3 25 | — | 49.8% | ||
| Q2 25 | — | 48.2% | ||
| Q1 25 | — | 48.7% | ||
| Q4 24 | — | 44.2% | ||
| Q3 24 | — | 48.1% | ||
| Q2 24 | — | 52.7% | ||
| Q1 24 | — | 52.6% |
营业利润率SPROTACT
| Q4 25 | — | -10.1% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | -1.9% | ||
| Q1 25 | -122758.3% | -0.1% | ||
| Q4 24 | — | -10.3% | ||
| Q3 24 | -28604.6% | -7.7% | ||
| Q2 24 | -16720.2% | -3.8% | ||
| Q1 24 | -9987.1% | -12.2% |
净利率SPROTACT
| Q4 25 | 250.7% | — | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | -1.0% | ||
| Q1 25 | -115550.0% | 0.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | -26380.0% | -5.1% | ||
| Q2 24 | -15668.4% | -2.8% | ||
| Q1 24 | -9049.3% | -9.7% |
每股收益（稀释后）SPROTACT
| Q4 25 | $0.56 | $-0.11 | ||
| Q3 25 | $-0.13 | $0.00 | ||
| Q2 25 | $-0.03 | $-0.01 | ||
| Q1 25 | $-0.25 | $0.00 | ||
| Q4 24 | — | $-0.80 | ||
| Q3 24 | $-0.32 | $-0.06 | ||
| Q2 24 | $-0.33 | $-0.03 | ||
| Q1 24 | $-0.24 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $40.3M | $20.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $59.0M | $31.1M |
| 总资产 | $68.9M | $44.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资SPROTACT
| Q4 25 | $40.3M | $20.4M | ||
| Q3 25 | $48.6M | $20.0M | ||
| Q2 25 | $31.2M | $17.7M | ||
| Q1 25 | $48.9M | $14.2M | ||
| Q4 24 | $52.9M | $14.4M | ||
| Q3 24 | $76.3M | $11.3M | ||
| Q2 24 | $63.5M | $11.1M | ||
| Q1 24 | $82.3M | $10.6M |
股东权益SPROTACT
| Q4 25 | $59.0M | $31.1M | ||
| Q3 25 | $26.5M | $31.8M | ||
| Q2 25 | $32.8M | $31.3M | ||
| Q1 25 | $33.8M | $30.9M | ||
| Q4 24 | $46.1M | $30.6M | ||
| Q3 24 | $65.5M | $38.4M | ||
| Q2 24 | $80.5M | $38.5M | ||
| Q1 24 | $96.2M | $38.6M |
总资产SPROTACT
| Q4 25 | $68.9M | $44.8M | ||
| Q3 25 | $54.2M | $45.0M | ||
| Q2 25 | $62.1M | $44.5M | ||
| Q1 25 | $77.7M | $44.2M | ||
| Q4 24 | $110.5M | $44.0M | ||
| Q3 24 | $135.2M | $50.5M | ||
| Q2 24 | $149.9M | $50.4M | ||
| Q1 24 | $167.7M | $51.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-8.4M | $609.0K |
| 自由现金流经营现金流 - 资本支出 | — | $589.0K |
| 自由现金流率自由现金流/营收 | — | 5.1% |
| 资本支出强度资本支出/营收 | — | 0.2% |
| 现金转化率经营现金流/净利润 | -0.26× | — |
| 过去12个月自由现金流最近4个季度 | — | $7.6M |
8季度趋势，按日历期对齐
经营现金流SPROTACT
| Q4 25 | $-8.4M | $609.0K | ||
| Q3 25 | $17.4M | $3.6M | ||
| Q2 25 | $-17.7M | $3.6M | ||
| Q1 25 | $-4.0M | $-161.0K | ||
| Q4 24 | $-23.4M | $2.4M | ||
| Q3 24 | $12.8M | $327.0K | ||
| Q2 24 | $-18.7M | $636.0K | ||
| Q1 24 | $5.9M | $-1.5M |
自由现金流SPROTACT
| Q4 25 | — | $589.0K | ||
| Q3 25 | — | $3.6M | ||
| Q2 25 | — | $3.6M | ||
| Q1 25 | — | $-171.0K | ||
| Q4 24 | — | $2.4M | ||
| Q3 24 | — | $259.0K | ||
| Q2 24 | — | $499.0K | ||
| Q1 24 | — | $-1.6M |
自由现金流率SPROTACT
| Q4 25 | — | 5.1% | ||
| Q3 25 | — | 27.1% | ||
| Q2 25 | — | 25.9% | ||
| Q1 25 | — | -1.3% | ||
| Q4 24 | — | 23.2% | ||
| Q3 24 | — | 2.4% | ||
| Q2 24 | — | 4.3% | ||
| Q1 24 | — | -14.9% |
资本支出强度SPROTACT
| Q4 25 | — | 0.2% | ||
| Q3 25 | — | 0.5% | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 0.6% | ||
| Q2 24 | — | 1.2% | ||
| Q1 24 | — | 1.0% |
现金转化率SPROTACT
| Q4 25 | -0.26× | — | ||
| Q3 25 | — | 242.00× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -8.47× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
